...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Eligibility for registered accounts in Canada

This the info from Sarah in TFSAs and RRSPs in 2017.  Link to the .pdf is no longer working.

Share
New Message
Please login to post a reply